3(R)-Aminomethyl-Pyrrolidine-1-Carboxylic Acid Tert-Butyl Ester

The substance catalogued under CAS 199174-48-8 and routinely referred to as (R)-1-Boc-3-aminomethylpyrrolidine or tert-butyl (3R)-3-(aminomethyl)pyrrolidine-1-carboxylate belongs to a class of N-protected chiral pyrrolidine derivatives employed as constrained diamine scaffolds in medicinal chemistry. Its molecular formula is C₁₀H₂₀N₂O₂, corresponding to a formula weight of 200.28 g·mol⁻¹. The compound presents as a colourless to pale yellow viscous oil or low-melting solid, exhibiting a measured specific rotation [α]_D²⁰ in the range of −12.0° to −14.5° (c = 1.0, CHCl₃) under anhydrous conditions. The tert-butyl carbamate (Boc) group installed on the pyrrolidine nitrogen provides orthogonal amine protection, stable to catalytic hydrogenolysis and nucleophilic bases, while the primary aminomethyl substituent at the 3-position remains available for reductive alkylation, acylation, or sulfonylation without disturbing the ring nitrogen.

Manufactured through catalytic asymmetric hydrogenation or chiral pool resolution pathways, the product is typically purified via fractional distillation under reduced pressure (0.08–0.15 mbar, head temperature 92–98 °C) followed by column chromatography on silica gel (eluent: CH₂Cl₂/MeOH 95:5 with 0.1% NH₄OH). The stereochemical integrity of the (R)-configuration at the pyrrolidine C-3 carbon is preserved throughout the synthetic sequence by avoiding strong mineral acids during workup; exposure to anhydrous HCl in ether induces immediate Boc cleavage, yielding the free diamine hydrochloride salt, which will racemize if heated above 60 °C in polar aprotic solvents.

Specification Profile and Analytical Concordance

Release testing across production-scale batches (typical campaign sizes 8–25 kg) follows a multi-parameter protocol anchored to pharmacopoeial general chapters. The primary assay method employs reverse-phase HPLC with UV detection at 200 nm using a C18 column (150 × 4.6 mm, 5 µm silica, 120 Å pore), mobile phase A: 0.1% trifluoroacetic acid in water, mobile phase B: acetonitrile, linear gradient from 5% to 95% B over 25 min. System suitability requirements mandate tailing factor ≤ 1.8 for the main peak and resolution from the closest byproduct ≥ 2.0. A typical product peak elutes at approximately 12.4 min under these conditions. The specification limits are documented in the accompanying table.

The chiral HPLC method utilizes an amylose-based tris(3,5-dimethylphenylcarbamate) stationary phase and is calibrated with a racemic certified reference material produced by mixing equimolar portions of the (R)- and (S)-enantiomers. Injecting a 10 µL aliquot of a 0.5 mg/mL sample solution achieves baseline resolution (Rs ≥ 2.8) between the two enantiomers. Temperature control of the column compartment at 25 ± 0.5 °C is mandatory; a shift of 3 °C alters retention time by approximately 0.35 min and reduces resolution by 15%.

What Limits the Shelf-Life of Sealed Bulk Containers at Ambient Temperature?

Accelerated stability studies performed on fluorinated high-density polyethylene (HDPE) drums placed inside secondary aluminized barrier foil bags under nitrogen purge indicate a primary degradation pathway involving slow carbamate hydrolysis at the Boc group, initiated by trace moisture ingress. At 40 °C / 75% RH, assay loss reaches 1.2% absolute after 90 days, accompanied by a proportional rise in free pyrrolidine amine content, detected by HILIC-MS at [M+H]⁺ = 101.1. The Arrhenius projection, assuming an activation energy of 68 kJ·mol⁻¹ derived from three-temperature modeling ( 25, 40, 60 °C), assigns a retest interval of 24 months when stored continuously at −20 °C under argon. Degradation accelerates sharply if the headspace relative humidity exceeds 30%: a single 24-hour exposure to ambient air at 55% RH can introduce enough sorbed moisture to violate the 0.3% KF specification, measurable as an endothermic event on DSC at 67–72 °C (attributed to water evaporation from the amorphous phase). Consequently, production facilities commonly subdivide bulk material into 100 g or 500 g septum-sealed glass bottles under glovebox conditions (O₂ ≤ 5 ppm, H₂O ≤ 1 ppm) immediately after final chromatographic purification.

The free aminomethyl group is sufficiently nucleophilic to react with atmospheric carbon dioxide, forming a solid carbamate salt crust at the oil–glass interface. This crust, once dislodged into the bulk liquid, interferes with downstream gravimetric dispensing and can cause filter plugging during syringe-based transfer operations. Recommendations for routine analytical sampling include passing the oil through a 0.2 μm PTFE syringe filter and discarding the first 2 mL of filtrate to eliminate adsorbed CO₂ adducts.

Why Does the N-Boc Derivative Excel Over N-Cbz and N-Fmoc Analogues in Radioligand Synthesis?

The tert-butyl carbamate protecting group exhibits an acidolytic lability profile ideally matched to solid-phase peptide synthesis cleave conditions where simultaneous deprotection and resin release are required. In a head-to-head comparison conducted under identical TFA/triisopropylsilane/water (95:2.5:2.5) conditions at 20 °C, complete deprotection of the Boc group from 3(R)-aminomethyl-pyrrolidine-1-carboxylic acid tert-butyl ester occurs within 12–15 min, while the Cbz analogue under transfer hydrogenolysis ( 10% Pd/C, 1 atm H₂, EtOH/HOAc) requires 3–5 h and generates benzyl alcohol as a side product that co-elutes with the desired diamine on SCX cartridges. The Fmoc variant, though deprotected rapidly with 20% piperidine in DMF, introduces dibenzofulvene–amine adduct formation unless a scavenger cocktail of 0.1 M hydroxylbenzotriazole is employed, complicating downstream ¹H-NMR purity assessment.

Furthermore, the non-polar tert-butyl moiety enhances the solubility of the protected building block in ethereal solvents (solubility in MTBE exceeds 250 mg·mL⁻¹ at 25 °C), a property exploited during liquid–liquid extraction workup of acylation mixtures. By contrast, the corresponding Cbz-protected substance precipitates from diethyl ether at concentrations above 60 mg·mL⁻¹, mandating chromatographic purification that adds 1.5–2.0 days to production cycle times for kilogram-scale batches.

When Batch-to-Batch Optical Rotation Drift Exceeds ±1.5°

Although chiral HPLC defines the enantiomeric purity specification, specific rotation continues to be monitored as a process control metric because it integrates contributions from residual solvent composition, moisture content, and trace metal coordination complexes that cannot be resolved by ion-exchange pretreatment alone. A routine root-cause investigation triggered when [α]_D for an incoming batch measures −10.8° versus the established acceptance band of −12.0° to −14.5° typically identifies one of three underlying contributors: (i) residual ethyl acetate above 8000 ppm introducing a levorotatory solvent interference, quantifiable by HS-GC with FID; (ii) palladium leaching from the hydrogenation catalyst at levels exceeding 15 ppm, which broadens the NMR linewidth of the carbamate N-H proton by 1.2–1.5 Hz and can be remediated by passage through a column of QuadraSil MP ( 5 wt% relative to substrate) prior to final distillation; or (iii) prolonged storage above −15 °C leading to transient water uptake that forms a liquid clathrate phase with altered chiroptical dispersion. In the latter scenario, dissolving the material in anhydrous toluene and concentrating under reduced pressure ( 40 °C, 15 mbar) restores rotation to within 0.8° of the reference value.

The choice between the (R) and (S) enantiomers is dictated exclusively by the stereochemical requirements of the biological target. In a panel of serine protease inhibitor programs, molecular docking studies regularly identify the (R)-configured pyrrolidine as the active enantiomer when the extended amine engages the S1 pocket in a gauche-minus torsion orientation, while the (S)-variant loses a critical hydrogen bond with Gly216 backbone carbonyl. Attempts to “flip” configuration by epimerization are not feasible once the ring is formed, because the stereocenter bears no acidic proton; thus procurement of a single enantiomer in high ee at the outset eliminates a downstream chiral resolution step estimated to cost US$ 320–450 per gram at the 500 g scale.

When contrasted with 3-(aminomethyl)piperidine-1-carboxylic acid tert-butyl ester, the pyrrolidine homologue offers a smaller N–C3–C4 torsion angle profile, resulting in a more compact projection of the aminomethyl vector and a 1.2 log unit lower calculated partition coefficient (clogP 0.82 versus 2.04 for the six-membered analogue). This translates into enhanced aqueous solubility of the final deprotected diamine (48 mg·mL⁻¹ in phosphate buffer pH 7.4 for the pyrrolidine versus 11 mg·mL⁻¹ for the piperidine), a parameter that often governs the feasibility of direct lyophilisation without organic co-solvent in parenteral formulation screening.